Selbst berichtete Infektionen in der NAKO Gesundheitsstudie - Einordnung in die gegenwärtige Forschungslandschaft [Self-reported infections in the German National Cohort (GNC) in the context of the current research landscape]

Autor: Hassenstein, M.J., Aarabi, G., Ahnert, P., Becher, H., Franzke, C.-W., Fricke, J., Krause, G., Glöckner, S., Gottschick, C., Karch, A., Kemmling, Y., Kerrinnes, T., Lange, B., Mikolajczyk, R., Nieters, A., Ott, J.J., Ahrens, W., Berger, K., Meinke-Franze, C., Gastell, S., Günther, K., Greiser, K.H., Holleczek, B., Horn, J., Jaeschke, L., Jagodzinski, A., Jansen, L., Jochem, C., Jöckel, K.H., Kaaks, R., Krist, L., Kuß, O., Langer, S., Legath, N., Leitzmann, M., Lieb, W., Loeffler, M., Mangold, N., Michels, K.B., Meisinger, C., Obi, N., Pischon, T., Schikowski, T., Schipf, S., Schulze, M.B., Stang, A., Waniek, S., Wirkner, K., Willich, S.N., Castell, S.

BACKGROUND: Infectious diseases continue to play an important role for disease perception, health-economic considerations and public health in Germany. In recent years, infectious diseases have been linked to the development of non-communicable disea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=mdc______med::5f91e7b5d18004e15a33e457488e53f0
http://edoc.mdc-berlin.de/18819/1/18819oa.pdf

Seroepidemiology of Borrelia burgdorferi s.l. among German National Cohort (NAKO) Participants, Hanover.

Autor: Hassenstein MJ; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.; PhD Programme 'Epidemiology' Braunschweig-Hannover, Germany., Janzen I; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany., Krause G; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.; German Center for Infection Research (DZIF), Braunschweig, Germany.; Hanover Medical School (MHH), 30625 Hannover, Germany.; TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture of the Hannover Medical School and Helmholtz Centre for Infection Research, 30625 Hannover, Germany., Harries M; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany., Melhorn V; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.; German Center for Infection Research (DZIF), Braunschweig, Germany., Kerrinnes T; Department of RNA-Biology of Bacterial Infections, Helmholtz Institute for RNA-Based Infection Research, 97080 Würzburg, Germany., Kemmling Y; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.; German Center for Infection Research (DZIF), Braunschweig, Germany., Castell S; Department of Epidemiology, Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.; German Center for Infection Research (DZIF), Braunschweig, Germany.; TWINCORE, Centre for Experimental and Clinical Infection Research, A Joint Venture of the Hannover Medical School and Helmholtz Centre for Infection Research, 30625 Hannover, Germany.

Publikováno v: Microorganisms [Microorganisms] 2022 Nov 17; Vol. 10 (11). Date of Electronic Publication: 2022 Nov 17.

The DNA polymerase of bacteriophage YerA41 replicates its T-modified DNA in a primer-independent manner.

Autor: Gomez-Raya-Vilanova MV; Department of Bacteriology and Immunology, Medicum, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00014 UH, Helsinki, Finland., Leskinen K; Department of Bacteriology and Immunology, Medicum, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00014 UH, Helsinki, Finland., Bhattacharjee A; Department of Bacteriology and Immunology, Medicum, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00014 UH, Helsinki, Finland.; Drug Discovery, Herantis Pharma Ltd. Bertel Jungin Aukio 1, 02600 Espoo, Finland., Virta P; Department of Chemistry, 20014 University of Turku, Turku, Finland., Rosenqvist P; Department of Chemistry, 20014 University of Turku, Turku, Finland., Smith JLR; York Structural Biology Laboratory, University of York, YO10 5DD York, United Kingdom., Bayfield OW; York Structural Biology Laboratory, University of York, YO10 5DD York, United Kingdom., Homberger C; Institute of Molecular Infection Biology (IMIB), University of Würzburg, D-97080 Würzburg, Germany., Kerrinnes T; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), D-97080 Würzburg, Germany., Vogel J; Institute of Molecular Infection Biology (IMIB), University of Würzburg, D-97080 Würzburg, Germany.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), D-97080 Würzburg, Germany.; Faculty of Medicine, University of Würzburg, D-97080 Würzburg, Germany., Pajunen MI; Department of Bacteriology and Immunology, Medicum, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00014 UH, Helsinki, Finland., Skurnik M; Department of Bacteriology and Immunology, Medicum, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, 00014 UH, Helsinki, Finland.; Division of Clinical Microbiology, HUSLAB, Helsinki University Hospital, 00290 Helsinki, Finland.

Publikováno v: Nucleic acids research [Nucleic Acids Res] 2022 Apr 22; Vol. 50 (7), pp. 3985-3997.

Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion

Autor: Faber, F, Tran, L, Byndloss, MX, Lopez, CA, Velazquez, EM, Kerrinnes, T, Nuccio, SP, Wangdi, T, Fiehn, O, Tsolis, RM, Bäumler, AJ

Publikováno v: Nature, vol 534, iss 7609
Faber, F; Tran, L; Byndloss, MX; Lopez, CA; Velazquez, EM; Kerrinnes, T; et al.(2016). Host-mediated sugar oxidation promotes post-antibiotic pathogen expansion. Nature, 534(7609), 697-699. doi: 10.1038/nature18597. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0kw8n087

© 2016 Macmillan Publishers Limited. All rights reserved. Changes in the gut microbiota may underpin many human diseases, but the mechanisms that are responsible for altering microbial communities remain poorly understood. Antibiotic usage elevates

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e49b3c95f4ad97cedb95f1c93b0d633c
https://escholarship.org/uc/item/0kw8n087

Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.

Autor: Becker M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Strengert M; Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.; TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany., Junker D; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Kaiser PD; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Kerrinnes T; Helmholtz-Institute for RNA-based Infection Research (HIRI), Würzburg, Germany., Traenkle B; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Pharmaceutical Biotechnology, University of Tübingen, Tübingen, Germany., Dinter H; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Pharmaceutical Biotechnology, University of Tübingen, Tübingen, Germany., Häring J; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Ghozzi S; Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany., Zeck A; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Weise F; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Peter A; Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.; German Center for Diabetes Research (DZD), München-Neuherberg, Germany., Hörber S; Institute for Clinical Chemistry and Pathobiochemistry, Department for Diagnostic Laboratory Medicine, University Hospital Tübingen, Tübingen, Germany.; Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.; German Center for Diabetes Research (DZD), München-Neuherberg, Germany., Fink S; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Ruoff F; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Dulovic A; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Bakchoul T; Institute for Clinical and Experimental Transfusion Medicine, University Hospital Tübingen, Tübingen, Germany., Baillot A; Niedersächsisches Landesgesundheitsamt, Department of Virology/Serology, Hannover, Germany., Lohse S; Institute of Virology, Saarland University Medical Center, Homburg/Saar, Germany., Cornberg M; Department of Gastroenterology, Hepatology, Endocrinology, Hannover Medical School, Hannover, Germany; Centre for Individualized Infection Medicine (CiiM), Hannover, Germany., Illig T; Hannover Unified Biobank (HUB), Hannover Medical School, Hannover, Germany., Gottlieb J; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.; Biomedical Research in End-stage and obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, Germany., Smola S; Institute of Virology, Saarland University Medical Center, Homburg/Saar, Germany., Karch A; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Berger K; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany., Rammensee HG; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Schenke-Layland K; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Women's Health, Research Institute for Women's Health, Eberhard-Karls-University, Tübingen, Germany.; Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Nelde A; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Märklin M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Heitmann JS; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Walz JS; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) and Robert Bosch Center for Tumor Diseases (RBCT), both Stuttgart, Germany., Templin M; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Joos TO; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany., Rothbauer U; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.; Pharmaceutical Biotechnology, University of Tübingen, Tübingen, Germany., Krause G; Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.; TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany., Schneiderhan-Marra N; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany. Nicole.Schneiderhan@nmi.de.

Publikováno v: Nature communications [Nat Commun] 2021 Feb 19; Vol. 12 (1), pp. 1152. Date of Electronic Publication: 2021 Feb 19.